Company: MYGN
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0000899923-25-000028
Chunk: 58

Company: MYRIAD GENETICS INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 58
---
(1) Represents the target number of PSUs awarded to our NEOs on March 14, 2024. To the extent the PSUs are determined to have been earned based on the performance metrics, the PSUs will vest on March 14, 2027. (2) The amounts represent the grant date fair value calculated in accordance with FASB ASC Topic 718. 67% of the units have a performance condition and are valued based on the closing price of our common stock on the Nasdaq Global Select Market on March 14, 2024 of $21.32. The other 33% of the units have a market condition and are valued using a Monte Carlo valuation model which resulted in a value of $28.87. 2022 Long-Term Incentive Awards In March 2022, the CHCC granted PSUs to our NEOs as part of our 2022 long-term incentive awards. The performance metrics and levels (threshold, target, and maximum) established by the CHCC for these PSUs are summarized in the chart below. The actual number of units earned was determined based on the percentage achievement of each predetermined performance target with no award earned if the minimum threshold was not achieved. Maximum payout was capped at 150% of the target number of PSUs granted. Relative total stockholder return was measured against the IXHC using the 20-trading day average at the beginning and end of the measurement period. In addition, the CHCC capped the number of PSUs earned with respect to the relative total stockholder return metric at target performance level if absolute total stockholder return was negative over the performance period. The measurement period for the relative total stockholder return metric was January 1, 2022 to December 31, 2024, and the revenue and adjusted EPS metrics were measured based on fiscal year 2024 results. In February 2025, the CHCC reviewed the achievement of the performance metrics for the PSUs granted in March 2022. The CHCC determined that the Company's total revenue during fiscal year 2024 was $837.6 million, resulting in an achievement level of 98%. The CHCC also determined that the Company's adjusted EPS for fiscal year 2024 was $0.13, which was below the threshold level of $0.38, resulting in an achievement level of 0%. The CHCC also determined that the Company's relative total stockholder return, as measured against the IXHC, ranked in the